Medical Care
Global Chronic Pain Topical Analgesics Market Research Report 2025
- May 12, 25
- ID: 236215
- Pages: 93
- Figures: 96
- Views: 1
The global market for Chronic Pain Topical Analgesics was valued at US$ 3108 million in the year 2024 and is projected to reach a revised size of US$ 4239 million by 2031, growing at a CAGR of 4.6% during the forecast period.
Topical analgesics are used to relieve pain and inflammation. They are commonly used to treat acute and chronic musculoskeletal pain and neuropathy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Topical Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Topical Analgesics.
The Chronic Pain Topical Analgesics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Pain Topical Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Topical Analgesics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Hisamitsu
Mylan
Lingrui
Teikoku Seiyaku
The Pure Source
Mercury Healthcare
Segment by Type
Analgesic Creams
Analgesic Sprays
Pain Relief Patches
Segment by Application
Muscle Pain
Arthritis Pain
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Pain Topical Analgesics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Topical analgesics are used to relieve pain and inflammation. They are commonly used to treat acute and chronic musculoskeletal pain and neuropathy.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chronic Pain Topical Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Pain Topical Analgesics.
The Chronic Pain Topical Analgesics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Pain Topical Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Pain Topical Analgesics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche (Genentech)
Amgen
B-MS
Merck
Pfizer
Novartis
Eli Lilly and Company
Johnson & Johnson
GSK
Sanofi
Boehringer Ingelheim
Zhejiang Jiuzhou Pharmaceutical
Hisamitsu
Mylan
Lingrui
Teikoku Seiyaku
The Pure Source
Mercury Healthcare
Segment by Type
Analgesic Creams
Analgesic Sprays
Pain Relief Patches
Segment by Application
Muscle Pain
Arthritis Pain
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Pain Topical Analgesics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Topical Analgesics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Analgesic Creams
1.2.3 Analgesic Sprays
1.2.4 Pain Relief Patches
1.3 Market by Application
1.3.1 Global Chronic Pain Topical Analgesics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Muscle Pain
1.3.3 Arthritis Pain
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Topical Analgesics Market Perspective (2020-2031)
2.2 Global Chronic Pain Topical Analgesics Growth Trends by Region
2.2.1 Global Chronic Pain Topical Analgesics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Pain Topical Analgesics Historic Market Size by Region (2020-2025)
2.2.3 Chronic Pain Topical Analgesics Forecasted Market Size by Region (2026-2031)
2.3 Chronic Pain Topical Analgesics Market Dynamics
2.3.1 Chronic Pain Topical Analgesics Industry Trends
2.3.2 Chronic Pain Topical Analgesics Market Drivers
2.3.3 Chronic Pain Topical Analgesics Market Challenges
2.3.4 Chronic Pain Topical Analgesics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Topical Analgesics Players by Revenue
3.1.1 Global Top Chronic Pain Topical Analgesics Players by Revenue (2020-2025)
3.1.2 Global Chronic Pain Topical Analgesics Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Pain Topical Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Pain Topical Analgesics Revenue
3.4 Global Chronic Pain Topical Analgesics Market Concentration Ratio
3.4.1 Global Chronic Pain Topical Analgesics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Topical Analgesics Revenue in 2024
3.5 Global Key Players of Chronic Pain Topical Analgesics Head office and Area Served
3.6 Global Key Players of Chronic Pain Topical Analgesics, Product and Application
3.7 Global Key Players of Chronic Pain Topical Analgesics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Topical Analgesics Breakdown Data by Type
4.1 Global Chronic Pain Topical Analgesics Historic Market Size by Type (2020-2025)
4.2 Global Chronic Pain Topical Analgesics Forecasted Market Size by Type (2026-2031)
5 Chronic Pain Topical Analgesics Breakdown Data by Application
5.1 Global Chronic Pain Topical Analgesics Historic Market Size by Application (2020-2025)
5.2 Global Chronic Pain Topical Analgesics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Pain Topical Analgesics Market Size (2020-2031)
6.2 North America Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
6.4 North America Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Topical Analgesics Market Size (2020-2031)
7.2 Europe Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
7.4 Europe Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Topical Analgesics Market Size (2020-2031)
8.2 Asia-Pacific Chronic Pain Topical Analgesics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Topical Analgesics Market Size (2020-2031)
9.2 Latin America Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
9.4 Latin America Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Topical Analgesics Market Size (2020-2031)
10.2 Middle East & Africa Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Details
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Introduction
11.1.4 Roche (Genentech) Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Chronic Pain Topical Analgesics Introduction
11.2.4 Amgen Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Details
11.3.2 B-MS Business Overview
11.3.3 B-MS Chronic Pain Topical Analgesics Introduction
11.3.4 B-MS Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Pain Topical Analgesics Introduction
11.4.4 Merck Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chronic Pain Topical Analgesics Introduction
11.5.4 Pfizer Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Chronic Pain Topical Analgesics Introduction
11.6.4 Novartis Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Introduction
11.7.4 Eli Lilly and Company Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Chronic Pain Topical Analgesics Introduction
11.9.4 GSK Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Chronic Pain Topical Analgesics Introduction
11.10.4 Sanofi Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Introduction
11.11.4 Boehringer Ingelheim Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.13 Hisamitsu
11.13.1 Hisamitsu Company Details
11.13.2 Hisamitsu Business Overview
11.13.3 Hisamitsu Chronic Pain Topical Analgesics Introduction
11.13.4 Hisamitsu Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.13.5 Hisamitsu Recent Development
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Chronic Pain Topical Analgesics Introduction
11.14.4 Mylan Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.14.5 Mylan Recent Development
11.15 Lingrui
11.15.1 Lingrui Company Details
11.15.2 Lingrui Business Overview
11.15.3 Lingrui Chronic Pain Topical Analgesics Introduction
11.15.4 Lingrui Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.15.5 Lingrui Recent Development
11.16 Teikoku Seiyaku
11.16.1 Teikoku Seiyaku Company Details
11.16.2 Teikoku Seiyaku Business Overview
11.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Introduction
11.16.4 Teikoku Seiyaku Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.16.5 Teikoku Seiyaku Recent Development
11.17 The Pure Source
11.17.1 The Pure Source Company Details
11.17.2 The Pure Source Business Overview
11.17.3 The Pure Source Chronic Pain Topical Analgesics Introduction
11.17.4 The Pure Source Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.17.5 The Pure Source Recent Development
11.18 Mercury Healthcare
11.18.1 Mercury Healthcare Company Details
11.18.2 Mercury Healthcare Business Overview
11.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Introduction
11.18.4 Mercury Healthcare Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.18.5 Mercury Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Pain Topical Analgesics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Analgesic Creams
1.2.3 Analgesic Sprays
1.2.4 Pain Relief Patches
1.3 Market by Application
1.3.1 Global Chronic Pain Topical Analgesics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Muscle Pain
1.3.3 Arthritis Pain
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Pain Topical Analgesics Market Perspective (2020-2031)
2.2 Global Chronic Pain Topical Analgesics Growth Trends by Region
2.2.1 Global Chronic Pain Topical Analgesics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chronic Pain Topical Analgesics Historic Market Size by Region (2020-2025)
2.2.3 Chronic Pain Topical Analgesics Forecasted Market Size by Region (2026-2031)
2.3 Chronic Pain Topical Analgesics Market Dynamics
2.3.1 Chronic Pain Topical Analgesics Industry Trends
2.3.2 Chronic Pain Topical Analgesics Market Drivers
2.3.3 Chronic Pain Topical Analgesics Market Challenges
2.3.4 Chronic Pain Topical Analgesics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Pain Topical Analgesics Players by Revenue
3.1.1 Global Top Chronic Pain Topical Analgesics Players by Revenue (2020-2025)
3.1.2 Global Chronic Pain Topical Analgesics Revenue Market Share by Players (2020-2025)
3.2 Global Chronic Pain Topical Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chronic Pain Topical Analgesics Revenue
3.4 Global Chronic Pain Topical Analgesics Market Concentration Ratio
3.4.1 Global Chronic Pain Topical Analgesics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Pain Topical Analgesics Revenue in 2024
3.5 Global Key Players of Chronic Pain Topical Analgesics Head office and Area Served
3.6 Global Key Players of Chronic Pain Topical Analgesics, Product and Application
3.7 Global Key Players of Chronic Pain Topical Analgesics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Pain Topical Analgesics Breakdown Data by Type
4.1 Global Chronic Pain Topical Analgesics Historic Market Size by Type (2020-2025)
4.2 Global Chronic Pain Topical Analgesics Forecasted Market Size by Type (2026-2031)
5 Chronic Pain Topical Analgesics Breakdown Data by Application
5.1 Global Chronic Pain Topical Analgesics Historic Market Size by Application (2020-2025)
5.2 Global Chronic Pain Topical Analgesics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chronic Pain Topical Analgesics Market Size (2020-2031)
6.2 North America Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
6.4 North America Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Pain Topical Analgesics Market Size (2020-2031)
7.2 Europe Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
7.4 Europe Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Pain Topical Analgesics Market Size (2020-2031)
8.2 Asia-Pacific Chronic Pain Topical Analgesics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2020-2025)
8.4 Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Pain Topical Analgesics Market Size (2020-2031)
9.2 Latin America Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
9.4 Latin America Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Pain Topical Analgesics Market Size (2020-2031)
10.2 Middle East & Africa Chronic Pain Topical Analgesics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2020-2025)
10.4 Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche (Genentech)
11.1.1 Roche (Genentech) Company Details
11.1.2 Roche (Genentech) Business Overview
11.1.3 Roche (Genentech) Chronic Pain Topical Analgesics Introduction
11.1.4 Roche (Genentech) Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.1.5 Roche (Genentech) Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Chronic Pain Topical Analgesics Introduction
11.2.4 Amgen Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 B-MS
11.3.1 B-MS Company Details
11.3.2 B-MS Business Overview
11.3.3 B-MS Chronic Pain Topical Analgesics Introduction
11.3.4 B-MS Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.3.5 B-MS Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Chronic Pain Topical Analgesics Introduction
11.4.4 Merck Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chronic Pain Topical Analgesics Introduction
11.5.4 Pfizer Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Chronic Pain Topical Analgesics Introduction
11.6.4 Novartis Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.6.5 Novartis Recent Development
11.7 Eli Lilly and Company
11.7.1 Eli Lilly and Company Company Details
11.7.2 Eli Lilly and Company Business Overview
11.7.3 Eli Lilly and Company Chronic Pain Topical Analgesics Introduction
11.7.4 Eli Lilly and Company Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.7.5 Eli Lilly and Company Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Pain Topical Analgesics Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.8.5 Johnson & Johnson Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 GSK Business Overview
11.9.3 GSK Chronic Pain Topical Analgesics Introduction
11.9.4 GSK Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.9.5 GSK Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Sanofi Business Overview
11.10.3 Sanofi Chronic Pain Topical Analgesics Introduction
11.10.4 Sanofi Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.10.5 Sanofi Recent Development
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Details
11.11.2 Boehringer Ingelheim Business Overview
11.11.3 Boehringer Ingelheim Chronic Pain Topical Analgesics Introduction
11.11.4 Boehringer Ingelheim Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.11.5 Boehringer Ingelheim Recent Development
11.12 Zhejiang Jiuzhou Pharmaceutical
11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details
11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.12.3 Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Introduction
11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.13 Hisamitsu
11.13.1 Hisamitsu Company Details
11.13.2 Hisamitsu Business Overview
11.13.3 Hisamitsu Chronic Pain Topical Analgesics Introduction
11.13.4 Hisamitsu Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.13.5 Hisamitsu Recent Development
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Chronic Pain Topical Analgesics Introduction
11.14.4 Mylan Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.14.5 Mylan Recent Development
11.15 Lingrui
11.15.1 Lingrui Company Details
11.15.2 Lingrui Business Overview
11.15.3 Lingrui Chronic Pain Topical Analgesics Introduction
11.15.4 Lingrui Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.15.5 Lingrui Recent Development
11.16 Teikoku Seiyaku
11.16.1 Teikoku Seiyaku Company Details
11.16.2 Teikoku Seiyaku Business Overview
11.16.3 Teikoku Seiyaku Chronic Pain Topical Analgesics Introduction
11.16.4 Teikoku Seiyaku Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.16.5 Teikoku Seiyaku Recent Development
11.17 The Pure Source
11.17.1 The Pure Source Company Details
11.17.2 The Pure Source Business Overview
11.17.3 The Pure Source Chronic Pain Topical Analgesics Introduction
11.17.4 The Pure Source Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.17.5 The Pure Source Recent Development
11.18 Mercury Healthcare
11.18.1 Mercury Healthcare Company Details
11.18.2 Mercury Healthcare Business Overview
11.18.3 Mercury Healthcare Chronic Pain Topical Analgesics Introduction
11.18.4 Mercury Healthcare Revenue in Chronic Pain Topical Analgesics Business (2020-2025)
11.18.5 Mercury Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Pain Topical Analgesics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Analgesic Creams
Table 3. Key Players of Analgesic Sprays
Table 4. Key Players of Pain Relief Patches
Table 5. Global Chronic Pain Topical Analgesics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chronic Pain Topical Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Chronic Pain Topical Analgesics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Chronic Pain Topical Analgesics Market Share by Region (2020-2025)
Table 9. Global Chronic Pain Topical Analgesics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Chronic Pain Topical Analgesics Market Share by Region (2026-2031)
Table 11. Chronic Pain Topical Analgesics Market Trends
Table 12. Chronic Pain Topical Analgesics Market Drivers
Table 13. Chronic Pain Topical Analgesics Market Challenges
Table 14. Chronic Pain Topical Analgesics Market Restraints
Table 15. Global Chronic Pain Topical Analgesics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Chronic Pain Topical Analgesics Market Share by Players (2020-2025)
Table 17. Global Top Chronic Pain Topical Analgesics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Topical Analgesics as of 2024)
Table 18. Ranking of Global Top Chronic Pain Topical Analgesics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Chronic Pain Topical Analgesics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Chronic Pain Topical Analgesics, Headquarters and Area Served
Table 21. Global Key Players of Chronic Pain Topical Analgesics, Product and Application
Table 22. Global Key Players of Chronic Pain Topical Analgesics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Pain Topical Analgesics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Chronic Pain Topical Analgesics Revenue Market Share by Type (2020-2025)
Table 26. Global Chronic Pain Topical Analgesics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Chronic Pain Topical Analgesics Revenue Market Share by Type (2026-2031)
Table 28. Global Chronic Pain Topical Analgesics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Chronic Pain Topical Analgesics Revenue Market Share by Application (2020-2025)
Table 30. Global Chronic Pain Topical Analgesics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Chronic Pain Topical Analgesics Revenue Market Share by Application (2026-2031)
Table 32. North America Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Chronic Pain Topical Analgesics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche (Genentech) Company Details
Table 48. Roche (Genentech) Business Overview
Table 49. Roche (Genentech) Chronic Pain Topical Analgesics Product
Table 50. Roche (Genentech) Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 51. Roche (Genentech) Recent Development
Table 52. Amgen Company Details
Table 53. Amgen Business Overview
Table 54. Amgen Chronic Pain Topical Analgesics Product
Table 55. Amgen Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 56. Amgen Recent Development
Table 57. B-MS Company Details
Table 58. B-MS Business Overview
Table 59. B-MS Chronic Pain Topical Analgesics Product
Table 60. B-MS Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 61. B-MS Recent Development
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Chronic Pain Topical Analgesics Product
Table 65. Merck Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Chronic Pain Topical Analgesics Product
Table 70. Pfizer Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Chronic Pain Topical Analgesics Product
Table 75. Novartis Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Eli Lilly and Company Company Details
Table 78. Eli Lilly and Company Business Overview
Table 79. Eli Lilly and Company Chronic Pain Topical Analgesics Product
Table 80. Eli Lilly and Company Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 81. Eli Lilly and Company Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Chronic Pain Topical Analgesics Product
Table 85. Johnson & Johnson Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. GSK Company Details
Table 88. GSK Business Overview
Table 89. GSK Chronic Pain Topical Analgesics Product
Table 90. GSK Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 91. GSK Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Chronic Pain Topical Analgesics Product
Table 95. Sanofi Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Chronic Pain Topical Analgesics Product
Table 100. Boehringer Ingelheim Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 101. Boehringer Ingelheim Recent Development
Table 102. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 103. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 104. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product
Table 105. Zhejiang Jiuzhou Pharmaceutical Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 106. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 107. Hisamitsu Company Details
Table 108. Hisamitsu Business Overview
Table 109. Hisamitsu Chronic Pain Topical Analgesics Product
Table 110. Hisamitsu Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 111. Hisamitsu Recent Development
Table 112. Mylan Company Details
Table 113. Mylan Business Overview
Table 114. Mylan Chronic Pain Topical Analgesics Product
Table 115. Mylan Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 116. Mylan Recent Development
Table 117. Lingrui Company Details
Table 118. Lingrui Business Overview
Table 119. Lingrui Chronic Pain Topical Analgesics Product
Table 120. Lingrui Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 121. Lingrui Recent Development
Table 122. Teikoku Seiyaku Company Details
Table 123. Teikoku Seiyaku Business Overview
Table 124. Teikoku Seiyaku Chronic Pain Topical Analgesics Product
Table 125. Teikoku Seiyaku Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 126. Teikoku Seiyaku Recent Development
Table 127. The Pure Source Company Details
Table 128. The Pure Source Business Overview
Table 129. The Pure Source Chronic Pain Topical Analgesics Product
Table 130. The Pure Source Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 131. The Pure Source Recent Development
Table 132. Mercury Healthcare Company Details
Table 133. Mercury Healthcare Business Overview
Table 134. Mercury Healthcare Chronic Pain Topical Analgesics Product
Table 135. Mercury Healthcare Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 136. Mercury Healthcare Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report
List of Figures
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. Global Chronic Pain Topical Analgesics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Pain Topical Analgesics Market Share by Type: 2024 VS 2031
Figure 4. Analgesic Creams Features
Figure 5. Analgesic Sprays Features
Figure 6. Pain Relief Patches Features
Figure 7. Global Chronic Pain Topical Analgesics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Chronic Pain Topical Analgesics Market Share by Application: 2024 VS 2031
Figure 9. Muscle Pain Case Studies
Figure 10. Arthritis Pain Case Studies
Figure 11. Chronic Pain Topical Analgesics Report Years Considered
Figure 12. Global Chronic Pain Topical Analgesics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Chronic Pain Topical Analgesics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chronic Pain Topical Analgesics Market Share by Region: 2024 VS 2031
Figure 15. Global Chronic Pain Topical Analgesics Market Share by Players in 2024
Figure 16. Global Top Chronic Pain Topical Analgesics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Topical Analgesics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Pain Topical Analgesics Revenue in 2024
Figure 18. North America Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 20. United States Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 24. Germany Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chronic Pain Topical Analgesics Market Share by Region (2020-2031)
Figure 32. China Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 40. Mexico Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 44. Turkey Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Roche (Genentech) Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 48. Amgen Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 49. B-MS Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 54. Johnson & Johnson Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 55. GSK Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 58. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 59. Hisamitsu Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 60. Mylan Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 61. Lingrui Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 62. Teikoku Seiyaku Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 63. The Pure Source Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 64. Mercury Healthcare Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Table 1. Global Chronic Pain Topical Analgesics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Analgesic Creams
Table 3. Key Players of Analgesic Sprays
Table 4. Key Players of Pain Relief Patches
Table 5. Global Chronic Pain Topical Analgesics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Chronic Pain Topical Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Chronic Pain Topical Analgesics Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Chronic Pain Topical Analgesics Market Share by Region (2020-2025)
Table 9. Global Chronic Pain Topical Analgesics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Chronic Pain Topical Analgesics Market Share by Region (2026-2031)
Table 11. Chronic Pain Topical Analgesics Market Trends
Table 12. Chronic Pain Topical Analgesics Market Drivers
Table 13. Chronic Pain Topical Analgesics Market Challenges
Table 14. Chronic Pain Topical Analgesics Market Restraints
Table 15. Global Chronic Pain Topical Analgesics Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Chronic Pain Topical Analgesics Market Share by Players (2020-2025)
Table 17. Global Top Chronic Pain Topical Analgesics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Topical Analgesics as of 2024)
Table 18. Ranking of Global Top Chronic Pain Topical Analgesics Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Chronic Pain Topical Analgesics Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Chronic Pain Topical Analgesics, Headquarters and Area Served
Table 21. Global Key Players of Chronic Pain Topical Analgesics, Product and Application
Table 22. Global Key Players of Chronic Pain Topical Analgesics, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Chronic Pain Topical Analgesics Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Chronic Pain Topical Analgesics Revenue Market Share by Type (2020-2025)
Table 26. Global Chronic Pain Topical Analgesics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Chronic Pain Topical Analgesics Revenue Market Share by Type (2026-2031)
Table 28. Global Chronic Pain Topical Analgesics Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Chronic Pain Topical Analgesics Revenue Market Share by Application (2020-2025)
Table 30. Global Chronic Pain Topical Analgesics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Chronic Pain Topical Analgesics Revenue Market Share by Application (2026-2031)
Table 32. North America Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Chronic Pain Topical Analgesics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Chronic Pain Topical Analgesics Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Chronic Pain Topical Analgesics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Chronic Pain Topical Analgesics Market Size by Country (2026-2031) & (US$ Million)
Table 47. Roche (Genentech) Company Details
Table 48. Roche (Genentech) Business Overview
Table 49. Roche (Genentech) Chronic Pain Topical Analgesics Product
Table 50. Roche (Genentech) Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 51. Roche (Genentech) Recent Development
Table 52. Amgen Company Details
Table 53. Amgen Business Overview
Table 54. Amgen Chronic Pain Topical Analgesics Product
Table 55. Amgen Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 56. Amgen Recent Development
Table 57. B-MS Company Details
Table 58. B-MS Business Overview
Table 59. B-MS Chronic Pain Topical Analgesics Product
Table 60. B-MS Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 61. B-MS Recent Development
Table 62. Merck Company Details
Table 63. Merck Business Overview
Table 64. Merck Chronic Pain Topical Analgesics Product
Table 65. Merck Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 66. Merck Recent Development
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Chronic Pain Topical Analgesics Product
Table 70. Pfizer Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Chronic Pain Topical Analgesics Product
Table 75. Novartis Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 76. Novartis Recent Development
Table 77. Eli Lilly and Company Company Details
Table 78. Eli Lilly and Company Business Overview
Table 79. Eli Lilly and Company Chronic Pain Topical Analgesics Product
Table 80. Eli Lilly and Company Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 81. Eli Lilly and Company Recent Development
Table 82. Johnson & Johnson Company Details
Table 83. Johnson & Johnson Business Overview
Table 84. Johnson & Johnson Chronic Pain Topical Analgesics Product
Table 85. Johnson & Johnson Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 86. Johnson & Johnson Recent Development
Table 87. GSK Company Details
Table 88. GSK Business Overview
Table 89. GSK Chronic Pain Topical Analgesics Product
Table 90. GSK Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 91. GSK Recent Development
Table 92. Sanofi Company Details
Table 93. Sanofi Business Overview
Table 94. Sanofi Chronic Pain Topical Analgesics Product
Table 95. Sanofi Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 96. Sanofi Recent Development
Table 97. Boehringer Ingelheim Company Details
Table 98. Boehringer Ingelheim Business Overview
Table 99. Boehringer Ingelheim Chronic Pain Topical Analgesics Product
Table 100. Boehringer Ingelheim Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 101. Boehringer Ingelheim Recent Development
Table 102. Zhejiang Jiuzhou Pharmaceutical Company Details
Table 103. Zhejiang Jiuzhou Pharmaceutical Business Overview
Table 104. Zhejiang Jiuzhou Pharmaceutical Chronic Pain Topical Analgesics Product
Table 105. Zhejiang Jiuzhou Pharmaceutical Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 106. Zhejiang Jiuzhou Pharmaceutical Recent Development
Table 107. Hisamitsu Company Details
Table 108. Hisamitsu Business Overview
Table 109. Hisamitsu Chronic Pain Topical Analgesics Product
Table 110. Hisamitsu Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 111. Hisamitsu Recent Development
Table 112. Mylan Company Details
Table 113. Mylan Business Overview
Table 114. Mylan Chronic Pain Topical Analgesics Product
Table 115. Mylan Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 116. Mylan Recent Development
Table 117. Lingrui Company Details
Table 118. Lingrui Business Overview
Table 119. Lingrui Chronic Pain Topical Analgesics Product
Table 120. Lingrui Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 121. Lingrui Recent Development
Table 122. Teikoku Seiyaku Company Details
Table 123. Teikoku Seiyaku Business Overview
Table 124. Teikoku Seiyaku Chronic Pain Topical Analgesics Product
Table 125. Teikoku Seiyaku Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 126. Teikoku Seiyaku Recent Development
Table 127. The Pure Source Company Details
Table 128. The Pure Source Business Overview
Table 129. The Pure Source Chronic Pain Topical Analgesics Product
Table 130. The Pure Source Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 131. The Pure Source Recent Development
Table 132. Mercury Healthcare Company Details
Table 133. Mercury Healthcare Business Overview
Table 134. Mercury Healthcare Chronic Pain Topical Analgesics Product
Table 135. Mercury Healthcare Revenue in Chronic Pain Topical Analgesics Business (2020-2025) & (US$ Million)
Table 136. Mercury Healthcare Recent Development
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 140. Authors List of This Report
List of Figures
Figure 1. Chronic Pain Topical Analgesics Picture
Figure 2. Global Chronic Pain Topical Analgesics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Chronic Pain Topical Analgesics Market Share by Type: 2024 VS 2031
Figure 4. Analgesic Creams Features
Figure 5. Analgesic Sprays Features
Figure 6. Pain Relief Patches Features
Figure 7. Global Chronic Pain Topical Analgesics Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Chronic Pain Topical Analgesics Market Share by Application: 2024 VS 2031
Figure 9. Muscle Pain Case Studies
Figure 10. Arthritis Pain Case Studies
Figure 11. Chronic Pain Topical Analgesics Report Years Considered
Figure 12. Global Chronic Pain Topical Analgesics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Chronic Pain Topical Analgesics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Chronic Pain Topical Analgesics Market Share by Region: 2024 VS 2031
Figure 15. Global Chronic Pain Topical Analgesics Market Share by Players in 2024
Figure 16. Global Top Chronic Pain Topical Analgesics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Pain Topical Analgesics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Pain Topical Analgesics Revenue in 2024
Figure 18. North America Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 20. United States Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 24. Germany Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Chronic Pain Topical Analgesics Market Share by Region (2020-2031)
Figure 32. China Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 40. Mexico Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Chronic Pain Topical Analgesics Market Share by Country (2020-2031)
Figure 44. Turkey Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Chronic Pain Topical Analgesics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Roche (Genentech) Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 48. Amgen Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 49. B-MS Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 52. Novartis Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 54. Johnson & Johnson Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 55. GSK Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 56. Sanofi Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 58. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 59. Hisamitsu Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 60. Mylan Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 61. Lingrui Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 62. Teikoku Seiyaku Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 63. The Pure Source Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 64. Mercury Healthcare Revenue Growth Rate in Chronic Pain Topical Analgesics Business (2020-2025)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232